Wavemaker Three-Sixty Health - aVenture Asset Manager Research
Location
Pasadena, CA, US
Founded
2018
Wavemaker Three-Sixty Health is a leading U.S. early-stage venture capital fund focused exclusively on healthcare. The firm primarily invests in seed-stage startups and often follows on at Series A, targeting innovative companies that are revolutionizing the healthcare industry. Their investment strategy emphasizes backing disruptive entrepreneurs who aim to make significant improvements in healthcare delivery and outcomes.
The fund's portfolio includes notable companies such as Carlsmed, DeepScribe, and TripleBlind, spanning various healthcare subsectors including medical devices, AI-powered healthcare solutions, and data privacy technologies. Wavemaker Three-Sixty Health provides value beyond capital, leveraging its industry expertise and network to support portfolio companies in their growth and development. The firm's commitment to healthcare innovation positions it as a key player in shaping the future of the industry.
Wavemaker Three-Sixty Health - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages